Home
Conditions
Hematological Malignancies

Clinical trial condition

Hematological Malignancies

Explore clinical trials studying Hematological Malignancies. Study availability and eligibility vary by location and protocol.

102 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Hematological Malignancies trial results

Not yet recruiting

Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France

NCT07541326

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: CHU Limoges Limoges, France

CH PAU Pau, France

View Trial Details

Not yet recruiting

Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

NCT07539779

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies

NCT07362602

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: Not specified

View Trial Details

Not yet recruiting

Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection

NCT07362732

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: Not specified

View Trial Details

Not yet recruiting

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)

NCT07047352

Conditions: Agranulocytosis, Carbapenem-resistant Enterobacterales, Cytopenia, +9 more
Locations: Rui Jin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

NCT06674330

Conditions: Critical Illness, Disease Attributes, Hematologic Diseases, +7 more
Locations: Not specified

View Trial Details

Not yet recruiting

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

NCT06180499

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies

NCT04662788

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies

NCT04657965

Conditions: Communicable Diseases, Disease Attributes, Hematologic Diseases, +9 more
Locations: The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Active, not recruiting

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

NCT03399799

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

City of Hope Duarte, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Mount Sinai Medical Center New York, United States

View all 13 locations

View Trial Details

Hematological Malignancies

Hematological Malignancies trial results

Related conditions